Literature DB >> 3926902

A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.

W Engels, J Endert, C P Van Boven.   

Abstract

A direct enzyme-linked immunoassay is described for the determination of C3 that becomes attached to the surface of bacteria upon incubation in serum. The assay uses horseradish peroxidase-conjugated rabbit antiserum specific for human C3. In this study various Pseudomonas aeruginosa strains, Escherichia coli and Staphylococcus aureus were opsonized under different conditions and the amount of C3 fixed to the bacterial surface was measured directly. The extent of C3 fixation was compared with the percentage of phagocytosis by human polymorphonuclear leukocytes and with the complement consumption in the fluid phase. It was demonstrated that C3 fixation closely correlated with the percentage of phagocytosis but not with complement consumption. The method can be performed with relatively simple equipment and could be used in routine laboratories in order to determine the extent of opsonization of Pseudomonas aeruginosa and other bacteria and to detect opsonic defects in the sera of patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926902     DOI: 10.1016/0022-1759(85)90120-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  11 in total

1.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.

Authors:  S V Hetherington
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

3.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.

Authors:  M F Tosi; H Zakem; M Berger
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis.

Authors:  R Tertti; E Eerola; O P Lehtonen; T H Ståhlberg; M Viander; A Toivanen
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

6.  The role of complement opsonization in interactions between F. tularensis subsp. novicida and human neutrophils.

Authors:  Jason H Barker; Ramona L McCaffrey; Nicki K Baman; Lee-Ann H Allen; Jerrold P Weiss; William M Nauseef
Journal:  Microbes Infect       Date:  2009-05-04       Impact factor: 2.700

7.  Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid.

Authors:  R G Bredius; P C Driedijk; M F Schouten; R S Weening; T A Out
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  A protective human monoclonal antibody directed to the outer core region of Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Terashima; I Uezumi; T Tomio; M Kato; K Irie; T Okuda; S Yokota; H Noguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

9.  Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; R A Hatch; K A Joiner
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

10.  Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.

Authors:  A O Wozencraft; J M Blackwell
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.